ISPC
ISPC
NASDAQ · Health Care

Ispecimen Inc

$3.97
-0.24 (-5.70%)
As of May 16, 2:35 AM ET ·
Financial Highlights (FY 2026)
Revenue
22.06M
Net Income
-119,954,187
Gross Margin
1.2%
Profit Margin
-543.7%
Rev Growth
-43.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 22.06M 38.69M 890.1K 703.7K
Gross Profit 275.8K 483.6K 415.1K 328.2K
Operating Income -102,688,104 -162,053,820 141.2K 92.5K
Net Income -119,954,187 -189,301,715 95.2K 101.7K
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Rev Growth -43.0% -43.0% +8.3% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.46M 1.43M
Total Equity 1.24M 1.20M
D/E Ratio 1.18 1.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -119,191,546 -198,548,077 175.3K 162.6K
Free Cash Flow 124.9K 90.2K